Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | -3.85% | -3.85% | +56.25% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other
100.0
%
| 0 | 5.9 % | 0 | 100.0 % | -4.95% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
93.1
%
| 1 | 55.5 % | 0 | 93.1 % | -90.63% |
Canada
6.9
%
| 1 | 44.5 % | 0 | 6.9 % | -99.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 17-09-04 |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 22-04-04 |
John Coleman
BRD | Director/Board Member | - | Nov. 15 |
Corporate Officer/Principal | - | 19-08-11 | |
Wendy Nachtigall
SAM | Sales & Marketing | - | 15-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 10-09-14 |
Chairman | 59 | Feb. 19 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-19 |
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
John Coleman
BRD | Director/Board Member | - | Nov. 15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,844,567 | 85,786,381 ( 65.07 %) | 0 | 65.07 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+56.25% | 12.54M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- KNE Stock
- Company Kane Biotech Inc.